OLP-1002 is Being Studied in the Treatment of Pain.
Clinical trial NCT03760913 · COMPLETED
Trial details
- NCT number
- NCT03760913
- Sponsor
- OliPass Corporation
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-21
- Primary completion
- 2020-10-16
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.